Philogen SpA
MIL:PHIL
Philogen SpA
MIL:PHIL
Price:
21
EUR
-0.47%
Market Closed
Market Cap:
€614m
Balance Sheet
Balance Sheet Decomposition
Philogen SpA
Philogen SpA
Balance Sheet Decomposition is not available for
Philogen SpA
Philogen SpA
Balance Sheet
Philogen SpA
Philogen SpA
Currency: EUR
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
6
|
6
|
4
|
12
|
9
|
24
|
16
|
31
|
|
| Cash |
6
|
6
|
4
|
12
|
9
|
24
|
16
|
31
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
28
|
31
|
71
|
50
|
93
|
62
|
60
|
83
|
|
| Total Receivables |
8
|
13
|
5
|
5
|
5
|
11
|
11
|
15
|
|
| Accounts Receivables |
4
|
9
|
1
|
1
|
1
|
3
|
3
|
4
|
|
| Other Receivables |
3
|
4
|
4
|
4
|
5
|
7
|
9
|
11
|
|
| Inventory |
1
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
43
|
51
|
80
|
68
|
108
|
99
|
89
|
132
|
|
| PP&E Net |
13
|
13
|
13
|
15
|
21
|
23
|
26
|
25
|
|
| PP&E Gross |
13
|
13
|
13
|
15
|
21
|
23
|
26
|
25
|
|
| Accumulated Depreciation |
9
|
10
|
7
|
8
|
10
|
12
|
16
|
18
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
|
| Long-Term Investments |
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
3
|
2
|
1
|
2
|
3
|
0
|
8
|
|
| Total Assets |
59
N/A
|
69
+17%
|
96
+39%
|
85
-11%
|
133
+55%
|
126
-5%
|
119
-5%
|
168
+41%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
2
|
3
|
4
|
6
|
6
|
8
|
10
|
|
| Accrued Liabilities |
0
|
1
|
1
|
0
|
1
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
11
|
11
|
1
|
2
|
2
|
2
|
2
|
1
|
|
| Other Current Liabilities |
1
|
9
|
8
|
7
|
3
|
2
|
2
|
4
|
|
| Total Current Liabilities |
14
|
23
|
14
|
13
|
12
|
11
|
13
|
17
|
|
| Long-Term Debt |
6
|
6
|
13
|
16
|
15
|
14
|
13
|
10
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
3
|
2
|
|
| Total Liabilities |
22
N/A
|
29
+34%
|
27
-6%
|
30
+9%
|
28
-7%
|
28
+1%
|
29
+3%
|
30
+4%
|
|
| Equity | |||||||||
| Common Stock |
4
|
4
|
5
|
5
|
6
|
6
|
6
|
6
|
|
| Retained Earnings |
14
|
16
|
8
|
6
|
21
|
15
|
11
|
44
|
|
| Additional Paid In Capital |
17
|
17
|
55
|
55
|
120
|
106
|
100
|
93
|
|
| Unrealized Security Profit/Loss |
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
|
| Other Equity |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Total Equity |
37
N/A
|
40
+8%
|
69
+71%
|
56
-19%
|
105
+89%
|
98
-7%
|
91
-7%
|
139
+53%
|
|
| Total Liabilities & Equity |
59
N/A
|
69
+17%
|
96
+39%
|
85
-11%
|
133
+55%
|
126
-5%
|
119
-5%
|
168
+41%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
41
|
41
|
41
|
41
|
41
|
40
|
40
|
40
|
|
Switch to:
Switch to:
See Also
Discover More
